Cargando…

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

BACKGROUND: We aim to characterize the heterogeneous circulating tumour cells (CTCs) in peripheral blood, independently of physical or immunological purification, by using patient-derived xenografts (PDXs) models. CTC studies from blood generally rely on enrichment or purification. Conversely, we de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agnoletto, Chiara, Minotti, Linda, Brulle-Soumare, Laura, Pasquali, Lorenzo, Galasso, Marco, Corrà, Fabio, Baldassari, Federica, Judde, Jean-Gabriel, Cairo, Stefano, Volinia, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208170/ https://www.ncbi.nlm.nih.gov/pubmed/30450210 http://dx.doi.org/10.1186/s40364-018-0145-8

Ejemplares similares

Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study
por: Galasso, Marco, et al.
Publicado: (2016)

The Network of Non-coding RNAs in Cancer Drug Resistance
por: Corrà, Fabio, et al.
Publicado: (2018)

SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
por: Minotti, Linda, et al.
Publicado: (2018)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
por: Baldassari, Federica, et al.
Publicado: (2018)

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
por: Corrà, Fabio, et al.
Publicado: (2021)

Mitochondria dysfunction in circulating tumor cells
por: Agnoletto, Chiara, et al.
Publicado: (2022)

Loss of miR-204 expression is a key event in melanoma
por: Galasso, Marco, et al.
Publicado: (2018)

The network of non-coding RNAs and their molecular targets in breast cancer
por: Crudele, Francesca, et al.
Publicado: (2020)

Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants
por: Tayoun, Tala, et al.
Publicado: (2022)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
por: Agnoletto, Chiara, et al.
Publicado: (2021)

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
por: Faugeroux, Vincent, et al.
Publicado: (2020)

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
por: Aguiari, Gianluca, et al.
Publicado: (2022)

Non-coding RNAs: a key to future personalized molecular therapy?
por: Galasso, Marco, et al.
Publicado: (2010)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
por: Gorges, Tobias M, et al.
Publicado: (2012)

Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
por: Terrazzan, Anna, et al.
Publicado: (2023)

Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype
por: Grassilli, Silvia, et al.
Publicado: (2022)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
por: Hoe, Susan Ling Ling, et al.
Publicado: (2017)

A KRAS-responsive long non-coding RNA controls microRNA processing
por: Shi, Lei, et al.
Publicado: (2021)

EpCAM(low) Circulating Tumor Cells: Gold in the Waste
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies
por: Antolovic, Dalibor, et al.
Publicado: (2010)

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
por: Spizzo, Gilbert, et al.
Publicado: (2011)

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
por: Franken, André, et al.
Publicado: (2023)

Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models
por: Li, Guanjie, et al.
Publicado: (2023)

Identification of microRNA activity by Targets' Reverse EXpression
por: Volinia, Stefano, et al.
Publicado: (2010)

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
por: Ang, Wei Xia, et al.
Publicado: (2017)

EpCAM as multi-tumour target for near-infrared fluorescence guided surgery
por: van Driel, P. B. A. A., et al.
Publicado: (2016)

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2015)

Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer
por: Brungs, Daniel, et al.
Publicado: (2020)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
por: Mikolajczyk, Stephen D., et al.
Publicado: (2011)

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2016)

ALCAM: A Novel Surface Marker on EpCAM(low) Circulating Tumor Cells
por: Signorelli, Rossana, et al.
Publicado: (2022)

Genetic Heterogeneity of Single Circulating Tumour Cells in Colorectal Carcinoma
por: Hamid, Faysal Bin, et al.
Publicado: (2020)

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer
por: Ostenfeld, Marie Stampe, et al.
Publicado: (2016)

EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases
por: Awasthi, Namrata Punit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b4ncf84b1pjf49r2nab2k8qoj0